The company did not disclose the value of the acquisition, which is aimed at expanding the company’s portfolio into real-time renal diagnostics.

Shares of Nuwellis Inc. (NUWE) slumped over 26% after-hours on Thursday after the company said that it has inked an agreement to acquire Israeli medical technology company Rendiatech.

Add Asianet Newsable as a Preferred SourcegooglePreferred

The company did not disclose the value of the deal that is aimed at expanding the company’s portfolio into real-time renal diagnostics. Rendiatech is focused on automated kidney function monitoring.

Separately, the Minneapolis-based company also announced a $5 million private placement and warrant inducement transaction. 

Get updates to this developing story directly on Stocktwits.<